- Home
- UTL vs PRME Comparison
UTL vs PRME Comparison
Compare UTL & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTL
- PRME
- Stock Information
- Founded
- UTL 1984
- PRME 2019
- Country
- UTL United States
- PRME United States
- Employees
- UTL N/A
- PRME N/A
- Industry
- UTL Power Generation
- PRME Medicinal Chemicals and Botanical Products
- Sector
- UTL Utilities
- PRME Health Care
- Exchange
- UTL Nasdaq
- PRME Nasdaq
- Market Cap
- UTL 811.5M
- PRME 693.5M
- IPO Year
- UTL N/A
- PRME 2022
- Fundamental
- Price
- UTL $45.84
- PRME $4.63
- Analyst Decision
- UTL Hold
- PRME Buy
- Analyst Count
- UTL 1
- PRME 6
- Target Price
- UTL $55.00
- PRME $8.88
- AVG Volume (30 Days)
- UTL 114.0K
- PRME 2.9M
- Earning Date
- UTL 11-03-2025
- PRME 11-11-2025
- Dividend Yield
- UTL 3.97%
- PRME N/A
- EPS Growth
- UTL N/A
- PRME N/A
- EPS
- UTL 2.91
- PRME N/A
- Revenue
- UTL $493,800,000.00
- PRME $4,961,000.00
- Revenue This Year
- UTL $7.06
- PRME $179.58
- Revenue Next Year
- UTL $7.63
- PRME N/A
- P/E Ratio
- UTL $15.59
- PRME N/A
- Revenue Growth
- UTL N/A
- PRME 739.42
- 52 Week Low
- UTL $44.61
- PRME $1.11
- 52 Week High
- UTL $63.52
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- UTL 44.04
- PRME 68.82
- Support Level
- UTL $45.19
- PRME $3.09
- Resistance Level
- UTL $46.77
- PRME $4.18
- Average True Range (ATR)
- UTL 0.89
- PRME 0.32
- MACD
- UTL 0.16
- PRME 0.13
- Stochastic Oscillator
- UTL 47.02
- PRME 86.15
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.